Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Phase I, randomized, double blind, placebo-controlled, dose-finding trial. The trial´s goal is to evaluate two different doses of Bryostatin on HIV-1 latency and reservoir in HIV-1 infected patients receiving antiretroviral treatment.
Epistemonikos ID: 8e6c4670bd427e0c356b91746b9514ff0e46bebe
First added on: May 12, 2024